760 related articles for article (PubMed ID: 15856067)
1. Endocannabinoid control of food intake and energy balance.
Di Marzo V; Matias I
Nat Neurosci; 2005 May; 8(5):585-9. PubMed ID: 15856067
[TBL] [Abstract][Full Text] [Related]
2. The endocannabinoid system: a new target for the regulation of energy balance and metabolism.
Després JP
Crit Pathw Cardiol; 2007 Jun; 6(2):46-50. PubMed ID: 17667864
[TBL] [Abstract][Full Text] [Related]
3. [Rimonabant (Acomplia), specific inhibitor of the endocannabinoid system].
Ducobu J; Sternon J
J Pharm Belg; 2005; 60(3):89-91. PubMed ID: 16252510
[TBL] [Abstract][Full Text] [Related]
4. Role of the endocannabinoid system in energy balance regulation and obesity.
Cota D
Front Horm Res; 2008; 36():135-145. PubMed ID: 18230900
[TBL] [Abstract][Full Text] [Related]
5. Feeding disorders and obesity.
Cervino C; Vicennati V; Pasquali R; Pagotto U
Curr Top Behav Neurosci; 2009; 1():373-85. PubMed ID: 21104392
[TBL] [Abstract][Full Text] [Related]
6. The challenge of treating obesity: the endocannabinoid system as a potential target.
Isoldi KK; Aronne LJ
J Am Diet Assoc; 2008 May; 108(5):823-31. PubMed ID: 18442506
[TBL] [Abstract][Full Text] [Related]
7. [Endocannabinoid and endocannabinoid receptor antagonists].
Heinzl S
Med Monatsschr Pharm; 2005 Feb; 28(2):40-3. PubMed ID: 15727333
[No Abstract] [Full Text] [Related]
8. The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use.
Xie S; Furjanic MA; Ferrara JJ; McAndrew NR; Ardino EL; Ngondara A; Bernstein Y; Thomas KJ; Kim E; Walker JM; Nagar S; Ward SJ; Raffa RB
J Clin Pharm Ther; 2007 Jun; 32(3):209-31. PubMed ID: 17489873
[TBL] [Abstract][Full Text] [Related]
9. The unfolding cannabinoid story on energy homeostasis: central or peripheral site of action?
Horvath TL
Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S30-2. PubMed ID: 16570102
[TBL] [Abstract][Full Text] [Related]
10. Photoperiodic changes in endocannabinoid levels and energetic responses to altered signalling at CB1 receptors in Siberian hamsters.
Ho JM; Smith NS; Adams SA; Bradshaw HB; Demas GE
J Neuroendocrinol; 2012 Jul; 24(7):1030-9. PubMed ID: 22420341
[TBL] [Abstract][Full Text] [Related]
11. The endocannabinoid system as a novel approach for managing obesity.
Lillo JL
J Am Osteopath Assoc; 2007 Apr; 107(4 Suppl 2):S12-20. PubMed ID: 17784530
[TBL] [Abstract][Full Text] [Related]
12. [Endocannabinoid system and energy metabolism: physiology and pathophysiology].
Pagotto U; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):74S-82S. PubMed ID: 18773754
[TBL] [Abstract][Full Text] [Related]
13. [A role for the endocannabinoid system in obesity].
Valenzuela C; Aguirre C; Castillo V; Ronco AM; Llanos M
Rev Med Chil; 2010 May; 138(5):621-9. PubMed ID: 20668819
[TBL] [Abstract][Full Text] [Related]
14. Endocannabinoid system and cardiometabolic risk.
Saavedra LE
Clin Pharmacol Ther; 2007 Nov; 82(5):591-4. PubMed ID: 17898706
[TBL] [Abstract][Full Text] [Related]
15. Central versus peripheral antagonism of cannabinoid CB1 receptor in obesity: effects of LH-21, a peripherally acting neutral cannabinoid receptor antagonist, in Zucker rats.
Pavón FJ; Serrano A; Pérez-Valero V; Jagerovic N; Hernández-Folgado L; Bermúdez-Silva FJ; Macías M; Goya P; de Fonseca FR
J Neuroendocrinol; 2008 May; 20 Suppl 1():116-23. PubMed ID: 18426510
[TBL] [Abstract][Full Text] [Related]
16. The endocannabinoid system as a target for the treatment of visceral obesity and metabolic syndrome.
Kyrou I; Valsamakis G; Tsigos C
Ann N Y Acad Sci; 2006 Nov; 1083():270-305. PubMed ID: 17148745
[TBL] [Abstract][Full Text] [Related]
17. Minireview: Endocannabinoids and their receptors as targets for obesity therapy.
de Kloet AD; Woods SC
Endocrinology; 2009 Jun; 150(6):2531-6. PubMed ID: 19372200
[TBL] [Abstract][Full Text] [Related]
18. The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning?
Bermudez-Silva FJ; Viveros MP; McPartland JM; Rodriguez de Fonseca F
Pharmacol Biochem Behav; 2010 Jun; 95(4):375-82. PubMed ID: 20347862
[TBL] [Abstract][Full Text] [Related]
19. [The endocannabinoid system].
Sudano I; Périat D; Noll G
Praxis (Bern 1994); 2008 Apr; 97(7):375-80. PubMed ID: 18548817
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoids in appetite control and the treatment of obesity.
Kirkham TC; Tucci SA
CNS Neurol Disord Drug Targets; 2006 Jun; 5(3):272-92. PubMed ID: 16787229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]